New drug EI1071 passes first safety check in healthy volunteers
Knowledge-focused
Completed
This early-stage study tested a new drug, EI1071, in 58 healthy adults to see if it is safe and how the body processes it. Participants received either single or multiple doses of the drug or a placebo. The main goal was to check for side effects and measure drug levels in the bl…
Phase: PHASE1 • Sponsor: Elixiron Immunotherapeutics Inc. • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:26 UTC